Table of Content

1 Klebsiella Pneumoniae Infection Drug Market Overview
1.1 Klebsiella Pneumoniae Infection Drug Product Overview
1.2 Klebsiella Pneumoniae Infection Drug Market Segment by Type
1.2.1 ATI-1503
1.2.2 CA-824
1.2.3 CC-1807
1.2.4 Cefiderocol
1.2.5 Debio-1454
1.2.6 EBX-004
1.2.7 Others
1.3 Global Klebsiella Pneumoniae Infection Drug Market Size by Type
1.3.1 Global Klebsiella Pneumoniae Infection Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Klebsiella Pneumoniae Infection Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2018-2024)
2 Global Klebsiella Pneumoniae Infection Drug Market Competition by Company
2.1 Global Top Players by Klebsiella Pneumoniae Infection Drug Sales (2018-2024)
2.2 Global Top Players by Klebsiella Pneumoniae Infection Drug Revenue (2018-2024)
2.3 Global Top Players by Klebsiella Pneumoniae Infection Drug Price (2018-2024)
2.4 Global Top Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends
2.5.1 Klebsiella Pneumoniae Infection Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Klebsiella Pneumoniae Infection Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Klebsiella Pneumoniae Infection Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Klebsiella Pneumoniae Infection Drug Market
2.8 Key Manufacturers Klebsiella Pneumoniae Infection Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Klebsiella Pneumoniae Infection Drug Status and Outlook by Region
3.1 Global Klebsiella Pneumoniae Infection Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Klebsiella Pneumoniae Infection Drug Historic Market Size by Region
3.2.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2018-2024)
3.2.3 Global Klebsiella Pneumoniae Infection Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Region
3.3.1 Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2024-2034)
3.3.3 Global Klebsiella Pneumoniae Infection Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Klebsiella Pneumoniae Infection Drug by Application
4.1 Klebsiella Pneumoniae Infection Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Klebsiella Pneumoniae Infection Drug Market Size by Application
4.2.1 Global Klebsiella Pneumoniae Infection Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2018-2024)
5 North America Klebsiella Pneumoniae Infection Drug by Country
5.1 North America Klebsiella Pneumoniae Infection Drug Historic Market Size by Country
5.1.1 North America Klebsiella Pneumoniae Infection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2018-2024)
5.2 North America Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Country
5.2.1 North America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2024-2034)
6 Europe Klebsiella Pneumoniae Infection Drug by Country
6.1 Europe Klebsiella Pneumoniae Infection Drug Historic Market Size by Country
6.1.1 Europe Klebsiella Pneumoniae Infection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2018-2024)
6.2 Europe Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Country
6.2.1 Europe Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Klebsiella Pneumoniae Infection Drug by Region
7.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Historic Market Size by Region
7.1.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2024-2034)
8 Latin America Klebsiella Pneumoniae Infection Drug by Country
8.1 Latin America Klebsiella Pneumoniae Infection Drug Historic Market Size by Country
8.1.1 Latin America Klebsiella Pneumoniae Infection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2018-2024)
8.2 Latin America Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Country
8.2.1 Latin America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Klebsiella Pneumoniae Infection Drug by Country
9.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Historic Market Size by Country
9.1.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Acies Bio doo
10.1.1 Acies Bio doo Company Information
10.1.2 Acies Bio doo Introduction and Business Overview
10.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Products Offered
10.1.5 Acies Bio doo Recent Development
10.2 Appili Therapeutics
10.2.1 Appili Therapeutics Company Information
10.2.2 Appili Therapeutics Introduction and Business Overview
10.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Products Offered
10.2.5 Appili Therapeutics Recent Development
10.3 Debiopharm International SA
10.3.1 Debiopharm International SA Company Information
10.3.2 Debiopharm International SA Introduction and Business Overview
10.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Products Offered
10.3.5 Debiopharm International SA Recent Development
10.4 Evaxion Biotech ApS
10.4.1 Evaxion Biotech ApS Company Information
10.4.2 Evaxion Biotech ApS Introduction and Business Overview
10.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Products Offered
10.4.5 Evaxion Biotech ApS Recent Development
10.5 F. Hoffmann-La Roche Ltd
10.5.1 F. Hoffmann-La Roche Ltd Company Information
10.5.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Products Offered
10.5.5 F. Hoffmann-La Roche Ltd Recent Development
10.6 FOB Synthesis Inc
10.6.1 FOB Synthesis Inc Company Information
10.6.2 FOB Synthesis Inc Introduction and Business Overview
10.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.6.5 FOB Synthesis Inc Recent Development
10.7 ImmunoClin Corp
10.7.1 ImmunoClin Corp Company Information
10.7.2 ImmunoClin Corp Introduction and Business Overview
10.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Products Offered
10.7.5 ImmunoClin Corp Recent Development
10.8 Innovation Pharmaceuticals Inc
10.8.1 Innovation Pharmaceuticals Inc Company Information
10.8.2 Innovation Pharmaceuticals Inc Introduction and Business Overview
10.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.8.5 Innovation Pharmaceuticals Inc Recent Development
10.9 Kyorin Pharmaceutical Co Ltd
10.9.1 Kyorin Pharmaceutical Co Ltd Company Information
10.9.2 Kyorin Pharmaceutical Co Ltd Introduction and Business Overview
10.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Products Offered
10.9.5 Kyorin Pharmaceutical Co Ltd Recent Development
10.10 Melinta Therapeutics Inc
10.10.1 Melinta Therapeutics Inc Company Information
10.10.2 Melinta Therapeutics Inc Introduction and Business Overview
10.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.10.5 Melinta Therapeutics Inc Recent Development
10.11 Nosopharm SAS
10.11.1 Nosopharm SAS Company Information
10.11.2 Nosopharm SAS Introduction and Business Overview
10.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Products Offered
10.11.5 Nosopharm SAS Recent Development
10.12 Peptilogics Inc
10.12.1 Peptilogics Inc Company Information
10.12.2 Peptilogics Inc Introduction and Business Overview
10.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.12.5 Peptilogics Inc Recent Development
10.13 Pfizer Inc
10.13.1 Pfizer Inc Company Information
10.13.2 Pfizer Inc Introduction and Business Overview
10.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Pfizer Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.13.5 Pfizer Inc Recent Development
10.14 Phico Therapeutics Ltd
10.14.1 Phico Therapeutics Ltd Company Information
10.14.2 Phico Therapeutics Ltd Introduction and Business Overview
10.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Products Offered
10.14.5 Phico Therapeutics Ltd Recent Development
10.15 Sarepta Therapeutics Inc
10.15.1 Sarepta Therapeutics Inc Company Information
10.15.2 Sarepta Therapeutics Inc Introduction and Business Overview
10.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.15.5 Sarepta Therapeutics Inc Recent Development
10.16 Shionogi & Co Ltd
10.16.1 Shionogi & Co Ltd Company Information
10.16.2 Shionogi & Co Ltd Introduction and Business Overview
10.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Products Offered
10.16.5 Shionogi & Co Ltd Recent Development
10.17 Syntiron LLC
10.17.1 Syntiron LLC Company Information
10.17.2 Syntiron LLC Introduction and Business Overview
10.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Syntiron LLC Klebsiella Pneumoniae Infection Drug Products Offered
10.17.5 Syntiron LLC Recent Development
10.18 Tetraphase Pharmaceuticals Inc
10.18.1 Tetraphase Pharmaceuticals Inc Company Information
10.18.2 Tetraphase Pharmaceuticals Inc Introduction and Business Overview
10.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Products Offered
10.18.5 Tetraphase Pharmaceuticals Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
11.4 Klebsiella Pneumoniae Infection Drug Market Dynamics
11.4.1 Klebsiella Pneumoniae Infection Drug Industry Trends
11.4.2 Klebsiella Pneumoniae Infection Drug Market Drivers
11.4.3 Klebsiella Pneumoniae Infection Drug Market Challenges
11.4.4 Klebsiella Pneumoniae Infection Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Klebsiella Pneumoniae Infection Drug Distributors
12.3 Klebsiella Pneumoniae Infection Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ATI-1503
Table 2. Major Company of CA-824
Table 3. Major Company of CC-1807
Table 4. Major Company of Cefiderocol
Table 5. Major Company of Debio-1454
Table 6. Major Company of EBX-004
Table 7. Major Company of Others
Table 8. Global Klebsiella Pneumoniae Infection Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (K Pcs)
Table 10. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US& Million)
Table 12. Global Klebsiella Pneumoniae Infection Drug Market Share in Value by Type (2018-2024)
Table 13. Global Klebsiella Pneumoniae Infection Drug Price by Type (2018-2024) & (USD/Pcs)
Table 14. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2024-2034) & (K Pcs)
Table 15. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type (2024-2034)
Table 18. Global Klebsiella Pneumoniae Infection Drug Price by Type (2024-2034) & (USD/Pcs)
Table 19. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (K Pcs)
Table 20. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Latin America Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2018-2024)
Table 28. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Klebsiella Pneumoniae Infection Drug Sales by Company (2018-2024) & (K Pcs)
Table 30. Global Klebsiella Pneumoniae Infection Drug Sales Share by Company (2018-2024)
Table 31. Global Klebsiella Pneumoniae Infection Drug Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Company (2018-2024)
Table 33. Global Market Klebsiella Pneumoniae Infection Drug Price by Company (2018-2024) & (USD/Pcs)
Table 34. Global Klebsiella Pneumoniae Infection Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Klebsiella Pneumoniae Infection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Klebsiella Pneumoniae Infection Drug as of 2022)
Table 37. Date of Key Manufacturers Enter into Klebsiella Pneumoniae Infection Drug Market
Table 38. Key Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Klebsiella Pneumoniae Infection Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2018-2024) & (K Pcs)
Table 42. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Region (2018-2024)
Table 45. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 46. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2024-2034) & (K Pcs)
Table 47. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Klebsiella Pneumoniae Infection Drug Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Region (2024-2034)
Table 50. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 51. Global Klebsiella Pneumoniae Infection Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (K Pcs)
Table 53. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application (2018-2024)
Table 56. Global Klebsiella Pneumoniae Infection Drug Price by Application (2018-2024) & (USD/Pcs)
Table 57. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2024-2034) & (K Pcs)
Table 58. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application (2024-2034)
Table 61. Global Klebsiella Pneumoniae Infection Drug Price by Application (2024-2034) & (USD/Pcs)
Table 62. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) (K Pcs)
Table 63. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Latin America Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) (K Pcs)
Table 71. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (K Pcs)
Table 73. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2018-2024)
Table 76. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (K Pcs)
Table 77. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (K Pcs)
Table 81. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (K Pcs)
Table 85. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2018-2024) & (K Pcs)
Table 89. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2024-2034) & (K Pcs)
Table 93. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (K Pcs)
Table 97. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (K Pcs)
Table 101. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (K Pcs)
Table 105. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (K Pcs)
Table 109. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Country (2024-2034)
Table 112. Acies Bio doo Company Information
Table 113. Acies Bio doo Introduction and Business Overview
Table 114. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product
Table 116. Acies Bio doo Recent Development
Table 117. Appili Therapeutics Company Information
Table 118. Appili Therapeutics Introduction and Business Overview
Table 119. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product
Table 121. Appili Therapeutics Recent Development
Table 122. Debiopharm International SA Company Information
Table 123. Debiopharm International SA Introduction and Business Overview
Table 124. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product
Table 126. Debiopharm International SA Recent Development
Table 127. Evaxion Biotech ApS Company Information
Table 128. Evaxion Biotech ApS Introduction and Business Overview
Table 129. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product
Table 131. Evaxion Biotech ApS Recent Development
Table 132. F. Hoffmann-La Roche Ltd Company Information
Table 133. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 134. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product
Table 136. F. Hoffmann-La Roche Ltd Recent Development
Table 137. FOB Synthesis Inc Company Information
Table 138. FOB Synthesis Inc Introduction and Business Overview
Table 139. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product
Table 141. FOB Synthesis Inc Recent Development
Table 142. ImmunoClin Corp Company Information
Table 143. ImmunoClin Corp Introduction and Business Overview
Table 144. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product
Table 146. ImmunoClin Corp Recent Development
Table 147. Innovation Pharmaceuticals Inc Company Information
Table 148. Innovation Pharmaceuticals Inc Introduction and Business Overview
Table 149. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product
Table 151. Innovation Pharmaceuticals Inc Recent Development
Table 152. Kyorin Pharmaceutical Co Ltd Company Information
Table 153. Kyorin Pharmaceutical Co Ltd Introduction and Business Overview
Table 154. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product
Table 156. Kyorin Pharmaceutical Co Ltd Recent Development
Table 157. Melinta Therapeutics Inc Company Information
Table 158. Melinta Therapeutics Inc Introduction and Business Overview
Table 159. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product
Table 161. Melinta Therapeutics Inc Recent Development
Table 162. Nosopharm SAS Company Information
Table 163. Nosopharm SAS Introduction and Business Overview
Table 164. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product
Table 166. Nosopharm SAS Recent Development
Table 167. Peptilogics Inc Company Information
Table 168. Peptilogics Inc Introduction and Business Overview
Table 169. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product
Table 171. Peptilogics Inc Recent Development
Table 172. Pfizer Inc Company Information
Table 173. Pfizer Inc Introduction and Business Overview
Table 174. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product
Table 176. Pfizer Inc Recent Development
Table 177. Phico Therapeutics Ltd Company Information
Table 178. Phico Therapeutics Ltd Introduction and Business Overview
Table 179. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product
Table 181. Phico Therapeutics Ltd Recent Development
Table 182. Sarepta Therapeutics Inc Company Information
Table 183. Sarepta Therapeutics Inc Introduction and Business Overview
Table 184. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 185. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product
Table 186. Sarepta Therapeutics Inc Recent Development
Table 187. Shionogi & Co Ltd Company Information
Table 188. Shionogi & Co Ltd Introduction and Business Overview
Table 189. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 190. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product
Table 191. Shionogi & Co Ltd Recent Development
Table 192. Syntiron LLC Company Information
Table 193. Syntiron LLC Introduction and Business Overview
Table 194. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 195. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product
Table 196. Syntiron LLC Recent Development
Table 197. Tetraphase Pharmaceuticals Inc Company Information
Table 198. Tetraphase Pharmaceuticals Inc Introduction and Business Overview
Table 199. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 200. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product
Table 201. Tetraphase Pharmaceuticals Inc Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Klebsiella Pneumoniae Infection Drug Market Trends
Table 205. Klebsiella Pneumoniae Infection Drug Market Drivers
Table 206. Klebsiella Pneumoniae Infection Drug Market Challenges
Table 207. Klebsiella Pneumoniae Infection Drug Market Restraints
Table 208. Klebsiella Pneumoniae Infection Drug Distributors List
Table 209. Klebsiella Pneumoniae Infection Drug Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Klebsiella Pneumoniae Infection Drug Product Picture
Figure 2. Global Klebsiella Pneumoniae Infection Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Klebsiella Pneumoniae Infection Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Klebsiella Pneumoniae Infection Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of ATI-1503
Figure 6. Global ATI-1503 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CA-824
Figure 8. Global CA-824 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of CC-1807
Figure 10. Global CC-1807 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Cefiderocol
Figure 12. Global Cefiderocol Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Debio-1454
Figure 14. Global Debio-1454 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of EBX-004
Figure 16. Global EBX-004 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2022 & 2034
Figure 21. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type in 2022
Figure 22. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type in 2022
Figure 23. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type in 2022
Figure 24. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type in 2022
Figure 27. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Klebsiella Pneumoniae Infection Drug Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Klebsiella Pneumoniae Infection Drug Revenue in 2022
Figure 33. Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Hospital
Figure 35. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Clinic
Figure 37. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2022 & 2034
Figure 42. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Klebsiella Pneumoniae Infection Drug Manufacturing Cost Structure
Figure 53. Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed